Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE

Nature Medicine

Volumn 12, Issue 5, 2006, Pages 518-525

  Liu, Yawei ^a   Teige, Ingrid ^a   Birnir, Bryndis ^b   Issazadeh Navikas, Shohreh ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; KI 67 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENCEPHALITOGENIC T CELL; GENE AMPLIFICATION; IMMUNOREGULATION; INFLAMMATION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; NEURONS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA;

EID: 33646596928     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1402     Document Type: Article

References (45)

1. Neumann, H., Cavalie, A., Jenne, D.E. & Wekerle, H. Induction of MHC class I genes in neurons. Science 269, 549-552 (1995).
2. Mott, R.T. et al. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 46, 369-379 (2004).
3. Moalem, G. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49-55 (1999).
4. Kerschensteiner, M. et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189, 865-870 (1999).
5. Medana, I. et al. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity. J. Immunol. 167, 674-681 (2001).
6. Flugel, A. et al. Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol. 10, 353-364 (2000).
7. Tian, L. et al. Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18. Eur. J. Immunol. 30, 810-818 (2000).
8. Tian, L., Yoshihara, Y., Mizuno, T., Mori, K. & Gahmberg, G.G. The neuronal glycoprotein telencephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin. J. Immunol. 158, 928-936 (1997).
9. Issazadeh, S., Kjellen, P., Olsson, T., Mustafa, M. & Holmdahl, R. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific. Eur. J. Immunol. 27, 1584-1587 (1997).
10. Issazadeh, S. et al. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta. J. Neuroimmunol. 69, 103-115 (1996).
11. Issazadeh, S. et al. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res. 40, 579-590 (1995).
12. Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M. & Khoury, S. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161, 1104-1112 (1998).
13. Chen, W. & Wahl, S.M. TGF-beta: receptors, signaling pathways and autoimmunity. Curr. Dir. Autoimmun. 5, 62-91 (2002).
14. Gorelik, L. & Flavell, R.A. Transform ing growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2, 46-53 (2002).
15. Gorelik, L. & Flavell, R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181 (2000).
16. Lucas, P.J., Kim, S.J., Melby, S.J. & Gress, R.E. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J. Exp. Med. 191, 1187-1196 (2000).
17. Santambrogio, L. et al. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J. Immunol. 151, 1116-1127 (1993).
18. +T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155, 1032-1036 (1995).
19. Hickey, W.F., Hsu, B.L. & Kimura, H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260 (1991).
20. Wekerle, H., Sun, D., Oropeza-Wekerle, R.L. & Meyermann, R. Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. J. Exp. Biol. 132, 43-57 (1987).
21. Flugel, A. et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14, 547-560 (2001).
22. Maehlen, J., Olsson, T., Zachau, A., Klareskog, L. & Kristensson, K. Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons. J. Neuroimmunol. 23, 125-132 (1989).
23. Estevez, A.G. et al. Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor. J. Neurosci. 18, 3708-3714 (1998).
24. Moalem, G., Monsonego, A., Shani, Y., Cohen, I.R. & Schwartz, M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 13, 1207-1217 (1999).
25. Hammarberg, H. et al. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20, 5283-5291 (2000).
26. Kerschensteiner, M., Stadelmann, C., Dechant, G., Wekerle, H. & Hohlfeld, R. Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann. Neurol. 53, 292-304 (2003).
27. Neumann, H., Boucraut, J., Hahnel, C., Misgeld, T. & Wekerle, H. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur. J. Neurosci. 8, 2582-2590 (1996).
28. Chan, A.C. et al. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J. 14, 2499-2508 (1995).
29. ten Dijke, P. & Hill, C.S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29, 265-273 (2004).
30. + T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 153, 3989-3996 (1994).
31. + T regulatory 1 cells to suppress antitumor immunity. J. Immunol. 175, 2931-2937 (2005).
32. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
33. Thompson, C. & Powrie, F. Regulatory T cells. Curr. Opin. Pharmacol. 4, 408-414 (2004).
34. Kullberg, M.C. et al. TGF-beta1 production by CD4(+)CD25(+) regulatory T cells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 35, 2886-2895 (2005).
35. Walunas, T.L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413 (1994).
36. Karandikar, N.J., Vanderlugt, C.L., Walunas, T.L., Miller, S.D. & Bluestone, J.A. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184, 783-788 (1996).
37. Nakada, M. et al. CD80 (B7-1) and CD86 (B7-2) antigens on house dust mite-specific T cells in atopic disease function through T-T cell interactions. J. Allergy Clin. Immunol. 104, 222-227 (1999).
38. + T cells engage in T-T cell interactions that mediate apoptosis: a model for lentivirus-induced T cell depletion. Vet. Immunol. Immunopathol. 98, 203-214 (2004).
39. Issazadeh, S., Zhang, M., Sayegh, M.H. & Khoury, S.J. Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model. J. Immunol. 162, 761-765 (1999).
40. Hurwitz, A.A., Sullivan, T.J., Sobel, R.A. & Allison, J.P. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc. Natl. Acad. Sci. USA 99, 3013-3017 (2002).
41. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. & Nishimune, Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313-319 (1997).
42. Teige, A. et al. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. J. Immunol. 172, 186-194 (2004).
43. Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R. & Issazadeh-Navikas, S. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170, 4776-4784 (2003).
44. Lyons, A.B. & Parish, C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131-137 (1994).
45. Campanella, M., Sciorati, C., Tarozzo, G. & Beltramo, M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33, 586-592 (2002).